BetterLife Pharma, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA08772P2026
CAD
0.07
-0.09 (-58.06%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Crescita Therapeutics, Inc.
Æterna Zentaris, Inc.
Telescope Innovations Corp.
NurExone Biologic, Inc.
PharmaTher Holdings Ltd.
PreveCeutical Medical, Inc.
BetterLife Pharma, Inc.
Pharmala Biotech Holdings, Inc.
Revive Therapeutics Ltd.
Core One Labs, Inc.
XORTX Therapeutics, Inc.
Why is BetterLife Pharma, Inc. ?
Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report
Verdict Report
Icon
No Data Found
Is BetterLife Pharma, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
BetterLife Pharma, Inc.
-100.0%
-0.16
115.05%
S&P/TSX 60
19.1%
1.43
14.72%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
11.19%
EBIT to Interest (avg)
-3.94
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.10
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
0
ROE (avg)
0.95%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.85
EV to EBIT
-3.60
EV to EBITDA
-3.60
EV to Capital Employed
-0.99
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

21What is working for the Company
OPERATING CASH FLOW(Y)

Highest at CAD -1.17 MM

DEBT-EQUITY RATIO (HY)

Lowest at -9.6 %

OPERATING PROFIT(Q)

Highest at CAD -0.47 MM

PRE-TAX PROFIT(Q)

Highest at CAD -0.39 MM

NET PROFIT(Q)

Highest at CAD -0.39 MM

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

-4What is not working for the Company
INTEREST(9M)

At CAD 0.17 MM has Grown at 63.34%

Here's what is working for BetterLife Pharma, Inc.
Operating Cash Flow
Highest at CAD -1.17 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CAD MM)

Operating Profit
Highest at CAD -0.47 MM and Grown
In each period in the last five periods
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (CAD MM)

Pre-Tax Profit
Highest at CAD -0.39 MM and Grown
In each period in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CAD MM)

Net Profit
Highest at CAD -0.39 MM and Grown
In each period in the last five periods
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (CAD MM)

Debt-Equity Ratio
Lowest at -9.6 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Pre-Tax Profit
At CAD -0.39 MM has Grown at 81.33%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CAD MM)

Net Profit
At CAD -0.39 MM has Grown at 80.14%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CAD MM)

Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for BetterLife Pharma, Inc.
Interest
At CAD 0.17 MM has Grown at 63.34%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CAD MM)